COVID-19 -- Worldwide/Unknown
A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
The companies still must
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8689484&promed&0
No comments:
Post a Comment